Christine Hummel is Senior Vice President of Manufacturer and Specialty Network Partnerships at Leap, which works directly with self-funded employers to manage specialty infusion benefits through a transparent, pass-through model. Christine explains how Leap coordinates care from product procurement to the infusion chair, what its new partnership with WeInfuse means for infusion center operators, and how a more transparent model can help employers keep pace with rising specialty spend.

A few highlights from the conversation:

• Leap passes product and infusion service costs straight through to employers, so they see exactly what they pay for.
• A clinical team of nurses and pharmacists handles prior authorization, scheduling, and care coordination, while hitting a Net Promoter Score of 92+.
• Patients who once drove hours to a hospital can receive infusions at home or at a center about 15 minutes away.
• Infusion centers in the Leap Transparency Network get pre-negotiated rates, prompt payment from Leap, and new volume for open chairs.
• Leap works with infusion providers three ways: ambulatory infusion centers, nursing networks, and specialty pharmacies that supply product.

Stay curious, join the conversation even when it feels uncomfortable, and help build a model where specialty innovation stays affordable for everyone who pays for it.

Connect with Leap:

• WeInfuse member page and meeting requests: leaphealth.com/infusion-partners/weinfuse
• Leap Transparency Network: ltn@leaphealth.com

Netalie Nadivi, Vice President of Strategy and Corporate Development at TailorMed, works on the barriers that stop patients from starting and staying on therapy. Netalie explains how financial toxicity quietly derails treatment, and what infusion centers can do to catch affordability problems before the first appointment.

A few highlights from the conversation:

• Why financial toxicity reaches well beyond oncology into any high cost, high complexity therapy.
• What affordability trouble looks like in a center, from an insured patient who cannot cover the balance to one weighing therapy against a mortgage payment.
• How the integration brings more than 6,000 assistance programs into the WeInfuse workflow, including manufacturer copay, foundation, free drug, bridge, and social determinants of health programs.
• Real time monitoring that moves a patient from a free drug program to a foundation the moment one opens, which can translate into millions of dollars for a practice.
• TailorMed Complete, the tech enabled service that pairs financial navigators with the platform when a practice has no capacity to work it in house.

Handle affordability upstream, well before the patient reaches the chair, and the right outcome for the patient becomes the right outcome for the practice.

Tracy Torgerson, Vice President of Infusion Services at Articularis Healthcare Group, leads infusion for a rheumatology group supporting independent practices across more than 28 locations. Tracy explains why profitability never happens by accident, and how dependable, repeatable processes let you catch a variation before it costs you money. A few highlights from the conversation: * Why she compares operations to a family recipe, and how everyone at the table knows when someone changes it. * The key performance indicators she watches most closely, including referral to chair time and how much inventory is sitting on the shelf. * How a 10 percent growth goal turned into a 20 percent increase across the system in nine months. * Her rule for scaling across many sites: standardize the process, not the personality. * Two principles for everyday compliance, and why she calls a near miss a good catch. Know your numbers, know your capacity, and follow your recipe to turn predictability into profitability.